Thursday, Aug 27th
Last update06:50:36 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 US healthcare officials recently said a food-poisoning outbreak tied to alfalfa sprouts and involving multiple germs... |
| ||
 Common personal care products widely contain unlabeled toxic chemicals, results from a new peer-reviewed study suggest.... |
 Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable... |
